Organization
Kiromic BioPharma
1 clinical trial
Clinical trial
Phase 1 Trial Evaluating the Safety and Tolerability of Gamma Delta T-Cell Infusions in Combination With Low Dose Radiotherapy in Subjects With Stage 4 Metastatic Non-Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2024-10-01